Stereotactic Radiotherapy for oligometastatic disease

Stereotactic Radiation (SABR) for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomesby Stephen Harrow et al (LANCET May 2022)https://lnkd.in/dg_G_fsM Randomized phase II trial.99 patients with a controlled primary tumor and 1 to 5 metastases, with all metastases amenable to SABR-palliative standard-of-care treatment (control arm) vs. SABR to all metastases + standard of care (SABR arm)-primary tumor sites included lung, …